tiprankstipranks
Trending News
More News >
Zhibao Technology Inc. Class A (ZBAO)
NASDAQ:ZBAO
US Market

Zhibao Technology Inc. Class A (ZBAO) AI Stock Analysis

Compare
12 Followers

Top Page

ZB

Zhibao Technology Inc. Class A

(NASDAQ:ZBAO)

52Neutral
Zhibao Technology Inc. has a moderate overall stock score driven by strong revenue growth but offset by inconsistent profitability and cash flow challenges. Technical indicators suggest weak market momentum, while the valuation indicates potential undervaluation. The lack of dividend yield and absence of earnings call or corporate event data provide limited additional insight.

Zhibao Technology Inc. Class A (ZBAO) vs. S&P 500 (SPY)

Zhibao Technology Inc. Class A Business Overview & Revenue Model

Company DescriptionZhibao Technology Inc., through its subsidiaries, provides digital insurance brokerage services in China. It also offers managing general underwriter services; healthcare; and offline insurance brokerage consulting services. The company was founded in 2015 and is based in Shanghai, China.
How the Company Makes MoneyZhibao Technology Inc. generates revenue primarily through the sale and licensing of its software products and solutions. It offers subscription-based services for its cloud platforms, which provide recurring revenue streams. The company also earns income through consulting and implementation services, assisting clients in integrating Zhibao's technologies into their existing systems. Additionally, strategic partnerships with industry leaders help expand its market reach and drive sales growth. Zhibao may also engage in collaborations to develop custom solutions, further contributing to its revenue.

Zhibao Technology Inc. Class A Financial Statement Overview

Summary
Zhibao Technology Inc. shows strong revenue growth with a significant increase in total revenue, but faces challenges in maintaining consistent profitability and managing cash flow. The balance sheet indicates manageable leverage but limited financial cushioning. Overall, while the company is growing, it needs to improve profitability consistency and cash flow management.
Income Statement
65
Positive
Zhibao Technology Inc. has demonstrated significant revenue growth over the past year, with total revenue jumping from $20.4M to $183.7M, indicating strong business development. The gross profit margin stands at 40.7%, reflecting effective cost management. However, volatile EBIT and net income figures suggest fluctuating operational efficiency, with a notable swing from a net loss to a net income of $13.3M. This variability presents a risk to consistent profitability.
Balance Sheet
50
Neutral
The company's balance sheet shows a moderate debt-to-equity ratio of 0.47, indicating manageable leverage levels. However, the equity ratio is relatively low at 30.6%, which might point to limited financial cushioning against liabilities. The return on equity (ROE) remains positive, yet highlights the necessity for strengthening equity and asset management to ensure sustainable growth.
Cash Flow
45
Neutral
Cash flow analysis reveals challenges, with negative operating cash flow of -$3.8M and free cash flow of -$4.4M, suggesting difficulties in generating cash from core operations. This negative cash flow to net income ratio signals potential liquidity issues. Despite substantial financing inflows, the company must improve its cash conversion efficiency to stabilize its financial standing.
Breakdown
Jun 2024Jun 2023Jun 2022Jun 2021
Income StatementTotal Revenue
183.67M20.43M16.76M6.89M
Gross Profit
74.76M7.95M6.78M3.14M
EBIT
10.11M-44.55M12.64M-35.76M
EBITDA
22.87M16.71M-32.48M12.29M
Net Income Common Stockholders
13.25M-6.40M1.96M-5.40M
Balance SheetCash, Cash Equivalents and Short-Term Investments
2.40M2.05M982.06K635.65K
Total Assets
208.79M17.63M14.33M10.74M
Total Debt
30.28M4.38M4.68M6.18M
Net Debt
27.88M2.34M3.70M5.55M
Total Liabilities
144.80M13.30M11.53M11.10M
Stockholders Equity
63.99M4.33M2.79M-357.89K
Cash FlowFree Cash Flow
-4.40M-419.11K-182.23K-2.73M
Operating Cash Flow
-3.81M-161.55K-153.23K-2.67M
Investing Cash Flow
-592.34K2.01M-494.74K-938.80K
Financing Cash Flow
30.91M-654.86K1.03M3.03M

Zhibao Technology Inc. Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.12
Price Trends
50DMA
1.22
Negative
100DMA
1.43
Negative
200DMA
2.47
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
47.59
Neutral
STOCH
57.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ZBAO, the sentiment is Negative. The current price of 1.12 is below the 20-day moving average (MA) of 1.14, below the 50-day MA of 1.22, and below the 200-day MA of 2.47, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.59 is Neutral, neither overbought nor oversold. The STOCH value of 57.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ZBAO.

Zhibao Technology Inc. Class A Risk Analysis

Zhibao Technology Inc. Class A disclosed 71 risk factors in its most recent earnings report. Zhibao Technology Inc. Class A reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Zhibao Technology Inc. Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$38.53M6.8340.01%
56
Neutral
$4.40B10.75-18.54%5.11%19.74%-53.52%
52
Neutral
$35.31M12.0448.31%80.80%
40
Underperform
$35.90M-554.86%
38
Underperform
$34.09M-559.73%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ZBAO
Zhibao Technology Inc. Class A
1.00
-2.89
-74.29%
INHD
Inno Holdings, Inc.
6.00
-0.16
-2.60%
FBLG
FibroBiologics, Inc.
0.90
-8.66
-90.59%
LGCL
Lucas GC Limited
0.46
-3.10
-87.08%
UBXG
U-BX Technology Ltd.
3.95
-80.05
-95.30%
BOLD
Boundless Bio Inc.
1.53
-8.37
-84.55%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.